AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVION LTD

0.082

-0.001-1.20%

Volume:37.20K

Turnover:3.05K

Market Cap:7.02M

PE:-0.67

High:0.082

Open:0.082

Low:0.082

Close:0.083

52wk High:0.200

52wk Low:0.075

Shares:85.65M

Float Shares:56.74M

Volume Ratio:0.87

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.122

EPS(LYR):-0.122

ROE:-77.64%

ROA:-44.16%

PB:0.85

PE(LYR):-0.67

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVION LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

4

Office Location:

385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia

Website:

http://www.inviongroup.com

Zip Code:

3000

Phone:

Fax:

- -

Introduction:

Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.082,"timestamp":1770777878251,"preClose":0.083,"halted":0,"volume":37195,"delay":0,"changeRate":-0.012048192771084347,"nameEN":"INVION LTD","floatShares":56741426,"shares":85647255,"eps":-0.122249,"marketStatus":"Trading","change":-0.001,"latestTime":"02-11 14:07:01 AEDT","open":0.082,"high":0.082,"low":0.082,"amount":3050,"amplitude":0,"askPrice":0.082,"askSize":7365,"bidPrice":0.081,"bidSize":90000,"shortable":3,"etf":0,"ttmEps":-0.122249,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770786000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.868914,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":56741426,"roa":"-44.16%","roe":"-77.64%","lyrEps":-0.122249,"volumeRatio":0.868914,"shares":85647255,"dividePrice":0,"high":0.082,"amplitude":0,"preClose":0.083,"low":0.082,"week52Low":0.075,"pbRate":"0.85","psRate":"2329.38","week52High":0.2,"institutionHeld":0,"latestPrice":0.082,"committee":0.848714,"eps":-0.122249,"divideRate":0,"volume":37195,"delay":0,"ttmEps":-0.122249,"open":0.082,"prevYearClose":0.093,"prevWeekClose":0.085,"prevMonthClose":0.092,"prevQuarterClose":0.093,"fiveDayClose":0.084,"twentyDayClose":0.09,"sixtyDayClose":0.081},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28625535,"yearFounded":2000,"employeeNum":4,"address":"385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9692 7222"},"stockCompanyDetail":{"websiteUrl":"http://www.inviongroup.com","stockEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.1075},{"period":"3month","weight":0.0247},{"period":"6month","weight":-0.0568},{"period":"1year","weight":-0.4276},{"period":"ytd","weight":-0.1075}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0033},{"period":"3month","weight":0.0114},{"period":"6month","weight":0.0682},{"period":"1year","weight":0.2023},{"period":"ytd","weight":0.0074}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.1875,"avgChangeRate":-0.039673},{"month":2,"riseRate":0.4375,"avgChangeRate":0.115888},{"month":3,"riseRate":0.25,"avgChangeRate":0.010159},{"month":4,"riseRate":0.1875,"avgChangeRate":-0.028761},{"month":5,"riseRate":0.25,"avgChangeRate":-0.088804},{"month":6,"riseRate":0.5625,"avgChangeRate":0.121519},{"month":7,"riseRate":0.25,"avgChangeRate":-0.039459},{"month":8,"riseRate":0.25,"avgChangeRate":0.048593},{"month":9,"riseRate":0.3125,"avgChangeRate":0.004366},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.041413},{"month":11,"riseRate":0.3125,"avgChangeRate":-0.053558},{"month":12,"riseRate":0.375,"avgChangeRate":0.119438}],"exchange":"ASX","name":"INVION LTD","nameEN":"INVION LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":null}}